GenScript Executive and Leadership Team

Patrick Liu, the Acting Chief Executive Officer, ProBio at GenScript, directs the strategic trajectory of the biologics contract development and manufacturing organization platform. Overseeing complex manufacturing workflows, Liu ensures the delivery of high-quality solutions to global research partners. This leadership role involves scaling production capabilities to meet the rigorous demands of the biotech industry. By optimizing operational efficiency within the CDMO division, Patrick Liu directly impacts the company's ability to support rapid therapeutic development. ProBio maintains a focus on innovation, ensuring that manufacturing processes remain at the forefront of scientific advancement. Through the alignment of technical resources and market requirements, Liu secures the competitive positioning of the organization. The Acting Chief Executive Officer, ProBio drives the expansion of service offerings, facilitating seamless transitions from early-stage research to commercial-scale production for clients worldwide.

Phil Zhou, the Chief Financial Officer at GenScript, manages the fiscal health and capital allocation strategies for the entire organization. Overseeing global financial reporting, Zhou ensures transparency and compliance across all business units, including the integrated cell therapy and industrial synthetic products platforms. This leadership role involves coordinating with the Board to drive long-term value creation and sustainable growth. By implementing robust financial controls, Phil Zhou directly impacts the operational stability of the company. The Chief Financial Officer monitors market trends to inform investment decisions, supporting the expansion of research services. Through rigorous analysis of revenue streams and cost structures, Zhou maintains the financial agility necessary for navigating the competitive biotech landscape. The Chief Financial Officer provides the essential economic framework that allows the company to scale its life sciences services and products effectively on a global level.

Patrick L., the President, Biosciences Group at GenScript, leads the primary life-science services and products platform to provide one-stop solutions for research communities. Overseeing the development of essential laboratory tools and reagents, Patrick L. ensures that the Biosciences Group meets the evolving needs of scientists worldwide. This leadership role involves driving innovation in synthetic biology and molecular research to maintain market leadership. By streamlining product delivery and enhancing service quality, Patrick L. directly impacts the productivity of global research institutions. The President, Biosciences Group coordinates with cross-functional teams to integrate new technologies into the existing service portfolio. Through the management of research-focused operations, the President supports the company's mission to accelerate scientific discovery. Patrick L. fosters a culture of excellence, ensuring that the Biosciences Group remains the preferred partner for researchers seeking reliable, high-performance biotech solutions across diverse international markets.

Janice Jin, the Division President, , Life Science Group, Genscript (APAC) at GenScript, directs all commercial operations and strategic initiatives throughout the Asia-Pacific region. Overseeing regional market expansion, Jin ensures that the Life Science Group delivers tailored biotech solutions to local research communities. This leadership role involves managing complex supply chains and fostering partnerships to strengthen the company's presence in key growth markets. By aligning regional activities with the broader corporate mission, Janice Jin directly impacts the overall revenue growth and brand recognition of the organization. The Division President, , Life Science Group, Genscript (APAC) monitors local regulatory environments and competitive dynamics to adapt service delivery models effectively. Through the optimization of regional sales and support networks, Jin facilitates the seamless integration of global products into the APAC market. The Division President, , Life Science Group, Genscript (APAC) drives operational excellence to ensure consistent service quality across the entire region.